Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |